BH4 5mg
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Augusta University
Overview
BH4 5mg is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
BH4 5mg clinical trials
Explore related
Medical disclaimer. This page summarizes research about BH4 5mg for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.